Back to Results
First PageMeta Content
Biotechnology / EuropaBio / Erik Tambuyzer / European Federation of Pharmaceutical Industries and Associations / Orphan drug / Rare disease / Pharmaceutical industry / European Medicines Agency / Pharmaceutical sciences / Pharmacology / Health


Document Date: 2011-08-11 10:45:12

Open Document

File Size: 155,29 KB

Share Result on Facebook

City

Brussels / /

Company

Celgene Corporation / European Biopharmaceutical Enterprises / /

Continent

Europe / /

/

IndustryTerm

healthcare innovation delivering / biopharmaceutical / biotechnology / pharmaceutical industry / biotechnology products / manufacturing / biotechnology arm / biopharmaceutical industry / medicinal products / /

MedicalCondition

rare and debilitating diseases / rare diseases / metabolic diseases / rare disease / musculoskeletal disorders / certain cancers / individual rare diseases / diseases / /

MedicalTreatment

innovative therapies / /

Organization

office of Health Economics / Task Force / EuropaBio’s Joint Rare Diseases and Orphan Medicinal Products Task Force / European Association for Bioindustries / Joint Task Force / EuropaBio / European Union / EBE-EuropaBio Joint Task Force / Joint Task Force on Rare Diseases & Orphan Medicinal Products / /

Person

Kevin Loth / Erik Tambuyzer / Emmanuel Chantelot / /

/

Position

Executive Director / Director / Chair / Joanna Dupont-Inglis Communications Manager / Director / External Relations / Europe / /

ProgrammingLanguage

EC / /

PublishedMedium

Health Economics / /

Technology

biotechnology / GSM / /

SocialTag